# Localized Leiomyosarcoma Biomarker Protocol

> **NCT04925089** · — · RECRUITING · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 40 (estimated)

## Conditions studied

- Leiomyosarcoma

## Interventions

- **OTHER:** Blood and Tissue collection

## Key facts

- **NCT ID:** NCT04925089
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-26
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04925089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04925089, "Localized Leiomyosarcoma Biomarker Protocol". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT04925089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*